HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1.

Abstract
The CC chemokine receptor-1 (CCR1) is a prime therapeutic target for treating autoimmune diseases. Through high capacity screening followed by chemical optimization, we identified a novel non-peptide CCR1 antagonist, R-N-[5-chloro-2-[2-[4-[(4-fluorophenyl)methyl]-2-methyl-1-piperazinyl ]-2-oxoethoxy]phenyl]urea hydrochloric acid salt (BX 471). Competition binding studies revealed that BX 471 was able to displace the CCR1 ligands macrophage inflammatory protein-1alpha (MIP-1alpha), RANTES, and monocyte chemotactic protein-3 (MCP-3) with high affinity (K(i) ranged from 1 nm to 5.5 nm). BX 471 was a potent functional antagonist based on its ability to inhibit a number of CCR1-mediated effects including Ca(2+) mobilization, increase in extracellular acidification rate, CD11b expression, and leukocyte migration. BX 471 demonstrated a greater than 10,000-fold selectivity for CCR1 compared with 28 G-protein-coupled receptors. Pharmacokinetic studies demonstrated that BX 471 was orally active with a bioavailability of 60% in dogs. Furthermore, BX 471 effectively reduces disease in a rat experimental allergic encephalomyelitis model of multiple sclerosis. This study is the first to demonstrate that a non-peptide chemokine receptor antagonist is efficacious in an animal model of an autoimmune disease. In summary, we have identified a potent, selective, and orally available CCR1 antagonist that may be useful in the treatment of chronic inflammatory diseases.
AuthorsM Liang, C Mallari, M Rosser, H P Ng, K May, S Monahan, J G Bauman, I Islam, A Ghannam, B Buckman, K Shaw, G P Wei, W Xu, Z Zhao, E Ho, J Shen, H Oanh, B Subramanyam, R Vergona, D Taub, L Dunning, S Harvey, R M Snider, J Hesselgesser, M M Morrissey, H D Perez
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 275 Issue 25 Pg. 19000-8 (Jun 23 2000) ISSN: 0021-9258 [Print] United States
PMID10748002 (Publication Type: Journal Article)
Chemical References
  • CCR1 protein, human
  • Ccr1 protein, rat
  • DNA, Complementary
  • Phenylurea Compounds
  • Piperidines
  • Receptors, CCR1
  • Receptors, Chemokine
  • BX 471
Topics
  • Administration, Oral
  • Animals
  • Binding, Competitive
  • Cell Line
  • DNA, Complementary
  • Dogs
  • Humans
  • Male
  • Phenylurea Compounds (administration & dosage, pharmacokinetics, pharmacology)
  • Piperidines (administration & dosage, pharmacokinetics, pharmacology)
  • Rats
  • Rats, Inbred Lew
  • Receptors, CCR1
  • Receptors, Chemokine (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: